1355 — Biosysen Balance Sheet
0.000.00%
Last trade - 00:00- HK$159.87m
- HK$251.96m
- HK$51.31m
Annual balance sheet for Biosysen, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 17 | 6.35 | 4.26 | 13.9 | 2.44 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4.79 | 16 | 1.07 | 0.965 | 5.46 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 26.5 | 29.4 | 9.22 | 17.8 | 20 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 205 | 159 | 112 | 54 | 43.3 |
| Net Goodwill | |||||
| Other Long Term Assets | |||||
| Total Assets | 240 | 196 | 127 | 75.1 | 80.4 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 85.8 | 90.8 | 81.4 | 73.3 | 86.6 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 228 | 194 | 164 | 117 | 116 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 12.3 | 2.18 | -36.3 | -42.4 | -35.3 |
| Total Liabilities & Shareholders' Equity | 240 | 196 | 127 | 75.1 | 80.4 |
| Total Common Shares Outstanding |